233 related articles for article (PubMed ID: 4151131)
1. [Pharmacologic basis and application of catecholamines in the treatment of shock].
Wang TG; Wang CW; Tseng YM
Zhonghua Yi Xue Za Zhi; 1974; 3():183-8. PubMed ID: 4151131
[No Abstract] [Full Text] [Related]
2. [Catecholamines and their therapeutic implications].
Wick A
Folia Clin Int (Barc); 1969 Sep; 19(9):428-36. PubMed ID: 4394471
[No Abstract] [Full Text] [Related]
3. Dopamine and other vaso-active agents in shock (edited summary).
Thompson WL
Scott Med J; 1979 Jan; 24(1):89-93. PubMed ID: 493938
[No Abstract] [Full Text] [Related]
4. [The effect of alpha and beta adrenergic stimulation and blockage in the normal and diabetic rat].
Korec R; Sofranková A
J Physiol (Paris); 1970; 62 Suppl 3():395-6. PubMed ID: 4396844
[No Abstract] [Full Text] [Related]
5. [The adrenergic system].
Lemaire P
Lille Med; 1975; 20(6):524-8. PubMed ID: 6845
[No Abstract] [Full Text] [Related]
6. [Effects of catecholamines on the neuromuscular blocking action of a non-depolarizing muscle relaxant--Part II. Experimental studies on the anti-neuromuscular blocking actions of catecholamines and the mechanisms of these actions in the dog].
Omote T; Namiki A; Iwasaki H
Masui; 1985 Nov; 34(11):1487-98. PubMed ID: 2868136
[No Abstract] [Full Text] [Related]
7. [Pharmacology of the adrenergic system. II. Interference of drugs with catecholamine storage in and release from the adrenergic system].
Ariëns EJ
Ned Tijdschr Geneeskd; 1970 Aug; 114(33):1369-76. PubMed ID: 4393655
[No Abstract] [Full Text] [Related]
8. Vasopressors and low-flow states.
Hershey SG; Altura BM
Clin Anesth; 1974; 10(1):31-76. PubMed ID: 4149702
[No Abstract] [Full Text] [Related]
9. Beta-adrenergic receptors: recognition and regulation.
Lefkowitz RJ
N Engl J Med; 1976 Aug; 295(6):323-8. PubMed ID: 6910
[No Abstract] [Full Text] [Related]
10. Use of corticosteroids in the treatment of shock.
Motsay GJ; Romero LH; Lillehei RC
Int Surg; 1974; 59(11-12):593-600. PubMed ID: 4443176
[No Abstract] [Full Text] [Related]
11. [Round table discussion on recent progress in the use of adreno-blocking and adreno-stimulating drugs. Introduction. General concepts concerning the pharmacology and physiopathology of the adrenergic receptors].
Panizon F
Minerva Pediatr; 1977 Mar; 29(7):371-8. PubMed ID: 17054
[No Abstract] [Full Text] [Related]
12. History of vasodilation in treating shock and low flow states.
Lillehei RC
Adv Shock Res; 1978; 1():1-17. PubMed ID: 45375
[No Abstract] [Full Text] [Related]
13. [Catecholamines in internal medicine emergencies].
Brandt D; Pristautz H; Klein W
Wien Med Wochenschr; 1984 Jul; 134(13-14):324-7. PubMed ID: 6495745
[TBL] [Abstract][Full Text] [Related]
14. [Beta adrenergic drugs and the cardiovascular system of the fetus and newborn infant].
Marini A
Minerva Pediatr; 1977 Mar; 29(7):391-8. PubMed ID: 17056
[No Abstract] [Full Text] [Related]
15. Adrenotropic drugs in lipid mobilization.
Wenke M
Horm Metab Res; 1970; 2():Suppl 2:55-62. PubMed ID: 4403190
[No Abstract] [Full Text] [Related]
16. Use of the mouse in pharmacodynamic testing.
Mundy RL; Teague RS
Ala J Med Sci; 1973 Oct; 10(4):425-38. PubMed ID: 4151528
[No Abstract] [Full Text] [Related]
17. [Role of catecholamines in gastric juice secretion].
Dzierzkowska J; Maśliński S
Acta Physiol Pol; 1982; 33 Suppl 24():45-54. PubMed ID: 6128864
[No Abstract] [Full Text] [Related]
18. The clinical use of dopamine in the treatment of shock.
Reid PR; Thompson WL
Johns Hopkins Med J; 1975 Dec; 137(6):276-9. PubMed ID: 1563
[TBL] [Abstract][Full Text] [Related]
19. [Drugs in shock treatment].
Dietzman RH; Motsay GJ; Lillehei RC
Internist (Berl); 1971 Mar; 12(3):103-7. PubMed ID: 4927712
[No Abstract] [Full Text] [Related]
20. Vasopressor agents in shock.
Moyer JH; Mills LC
Am J Nurs; 1975 Apr; 75(4):620-5. PubMed ID: 1039254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
